News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

More Details About Hisun-Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK)-Simcere Pharmaceutical Group JVs



5/21/2013 8:51:25 AM

by Richard Daverman, PhD

May 21, 2013 -- In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were high-profile, and their aims went beyond drug distributorship, reaching into drug development. But details have been slow to emerge. A recent article in People’s Daily shed some light on these important JVs, which are now just getting under way. More details....

Stock Symbols: (NYSE: PFE) (NYSE: MRK) (SHA: 600267) (NYSE: SCR)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES